Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Killing a cancer cell from the inside out

By R&D Editors | September 6, 2011

Cancer Cell Death

An image of a cancer cell undergoing apoptosis (cell death). Image: National Cancer Institute

Researchers
at the Massachusetts Institute of Technology (MIT) and Switzerland’s ETH Zurich have found a way to program cells to
determine whether they have become cancerous, and if they have, to order their
own suicide.

The
new technology, described in Science, offers the possibility of
designing cell-death-inducing programs specific to any type of cancer, which
could effectively kill tumors while leaving healthy tissues unharmed.

To
create their tumor-killing program, the researchers designed a logic circuit—a
system that makes a decision based on multiple inputs. In this case, the
circuit is made of genes that detect molecules specific to a type of cervical
cancer cell. If the right molecules are present, the genes initiate production
of a protein that stimulates apoptosis, or programmed cell death. If not,
nothing happens.

Because
the genes used to create the circuits can be easily swapped in and out, this
approach could also yield new treatments or diagnostics for many other
diseases, says Ron Weiss, an MIT associate professor of biological engineering
and one of the leaders of the research team. “This is a general technology for
disease-state detection,” he says.

Yaakov
Benenson of ETH Zurich (the Swiss Federal
Institute of Technology in Zurich) co-led the
research team, which also included first author and MIT postdoc Zhen Xie, MIT
postdoc Liliana Wroblewska, and Laura Prochazka of ETH Zurich.

Targeting microRNA

The researchers chose a type of genetic material called microRNA (miRNA) as
their target. These snippets of RNA, discovered only 10 years ago, help
regulate gene expression by selectively destroying messenger RNA, which relays
DNA’s instructions to the rest of the cell.

There
are about 1,000 different miRNA sequences found in humans. Cancer cells often
have too much of some miRNAs and too little of others; each distinct type of
cancer has its own miRNA profile.

In
this paper, the researchers wanted to distinguish a particular type of cervical
cancer cell, known as HeLa, from other cancer cells. To do that, they
identified six miRNAs—some found in large numbers in HeLa cells, others in low
numbers—that, taken together, differentiate HeLa from any other cancer cell.

Then,
the researchers created a synthetic gene for a protein, called hBax, that promotes
cell death. They designed the gene with two separate safeguards against the
killing of healthy, non-HeLa cells: It can be turned off by high levels of miRNAs
that are ordinarily low in HeLa, and can also be deactivated by low levels of
miRNAs that are normally plentiful in HeLa. A single discrepancy from the
target miRNA profile is enough to shut off production of the cell-death
protein.

If
all miRNA levels match up with the HeLa profile, the protein is produced and
the cell dies. In any other cell, the protein never gets made, and the synthetic
genes eventually break down.

A complex state

The researchers are now working on optimizing the circuit to eliminate any
false positives and developing new circuits that can identify additional cell
types. They also hope to test the approach in living animals and eventually
humans.

They
are also investigating possible methods to package and deliver the DNA that
comprises the circuit, in collaboration with MIT chemical engineers Robert
Langer and Daniel Anderson.

SOURCE

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE